Magistral Phage Preparations: Is This the Model for Everyone?

Phage Therapy in Germany—Update 2023

(2023) Christian Willy et al.   Viruses-Basel

Compassionate Use of Bacteriophages for Failed Persistent Infections During the First 5 Years of the Israeli Phage Therapy Center

(2023) Hadil Onallah et al.   Open Forum Infectious Diseases

Considerations for the Use of Phage Therapy in Clinical Practice

(2022) Gina A. Suh et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review

(2022) Saartje Uyttebroek et al.   LANCET INFECTIOUS DISEASES

Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection

(2022) T. Ferry et al.   Nature Communications

Bacteriophage-antibiotic combination therapy against extensively drug-resistant Pseudomonas aeruginosa infection to allow liver transplantation in a toddler

(2022) Brieuc Van Nieuwenhuyse et al.   Nature Communications

Bacteriophages as Biocontrol Agents in Livestock Food Production

(2022) Logan Gildea et al.   Microorganisms

Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019

(2022) Kevin S Ikuta et al.   LANCET

Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial

(2022) Ameneh Khatami et al.   BMJ Open

How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment

(2021) Michael Schlander et al.   PHARMACOECONOMICS

Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol)

(2021) Jolien Onsea et al.   Viruses-Basel

European regulatory aspects of phage therapy: magistral phage preparations

(2021) Gilbert Verbeken et al.   Current Opinion in Virology

Phage Therapy in the Year 2035

(2020) Jean-Paul Pirnay   Frontiers in Microbiology

Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products

(2020) Laurent Bretaudeau et al.   Frontiers in Microbiology

Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery

(2020) Evgenii Rubalskii et al.   Antibiotics-Basel

Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial

(2020) Lorenz Leitner et al.   LANCET INFECTIOUS DISEASES

Bacteriophages: it's a medicine, Jim, but not as we know it

(2020) Jean-Paul Pirnay et al.   LANCET INFECTIOUS DISEASES

Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States

(2020) Saima Aslam et al.   Open Forum Infectious Diseases

Processing Phage Therapy Requests in a Brussels Military Hospital: Lessons Identified

(2019) Sarah Djebara et al.   Viruses-Basel

Salvage therapy with Sodium chlorosum (formerly DAC N-055) for cases of refractory lupoid cutaneous leishmaniasis: results from a compassionate use study with 0.09% Sodium chlorosum in amphiphilic basic cream

(2019) Sara Molkara et al.   BMC INFECTIOUS DISEASES

The Magistral Phage

(2018) Jean-Paul Pirnay et al.   Viruses-Basel

Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial

(2018) Patrick Jault et al.   LANCET INFECTIOUS DISEASES

Impact of the Council of Europe Resolution on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients

(2016) H P A Scheepers et al.   European Journal of Hospital Pharmacy-Science and Practice

Legislation on the preparation of medicinal products in European pharmacies and the Council of Europe Resolution

(2016) H PA Scheepers et al.   European Journal of Hospital Pharmacy-Science and Practice

Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences

(2016) Nina Chanishvili   Current Drug Delivery

Pre-adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution withPseudomonas aeruginosacystic fibrosis bacterial isolates

(2015) V-P. Friman et al.   JOURNAL OF EVOLUTIONARY BIOLOGY

Experience of the Eliava Institute in bacteriophage therapy

(2015) Mzia Kutateladze   VIROLOGICA SINICA

Taking Bacteriophage Therapy Seriously: A Moral Argument

(2014) Gilbert Verbeken et al.   Biomed Research International

Business oriented EU human cell and tissue product legislation will adversely impact Member States’ health care systems

(2013) Jean-Paul Pirnay et al.   CELL AND TISSUE BANKING

Optimizing the European Regulatory Framework for Sustainable Bacteriophage Therapy in Human Medicine

(2012) Gilbert Verbeken et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Bacteria-Phage Antagonistic Coevolution in Soil

(2011) P. Gomez et al.   SCIENCE

The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

(2010) Jean-Paul Pirnay et al.   PHARMACEUTICAL RESEARCH

Brève histoire de la phagothérapie

(2008) A. Dublanchet et al.   MEDECINE ET MALADIES INFECTIEUSES